Hodgkin lymphoma survival statistics

Survival

Survive Hodgkin lymphoma for 10 or more years, 2010-11, England and Wales

Age

Age that Hodgkin lymphoma survival is highest, 2009-2013, England

 

Improvement

Hodgkin lymphoma survival in the UK has increased in the last 40 years

 

91% of men survive Hodgkin lymphoma for at least one year, and this is predicted to fall to 84% surviving for five years or more, as shown by age-standardised Open a glossary item net survival for patients diagnosed with Hodgkin lymphoma during 2010-2011 in England and Wales.[1] Survival for women is slightly higher, with 92% surviving for one year or more, and 86% predicted to survive for at least five years.

Hodgkin Lymphoma (C81), Age-Standardised One-, Five- and Ten-Year Net Survival, Adults (Aged 15-99), England and Wales, 2010-2011

1-Year Survival (%) 5-Year Survival (%) 10-Year Survival (%)
Men Net Survival 90.7 84.2 78.5
95% LCL 90.7 84.2 78.4
95% UCL 90.7 84.2 78.5
Women Net Survival 92.2 86.0 82.9
95% LCL 92.2 86.0 82.9
95% UCL 92.2 86.0 83.0
Adults Net Survival 91.4 85.0 80.4
95% LCL 91.4 84.9 80.3
95% UCL 91.4 85.0 80.4

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item

Five- and ten-year survival is predicted using an excess hazard statistical model

Hodgkin lymphoma survival gradually continues to fall beyond five years after diagnosis. 79% of men and 83% of women are predicted to survive their disease for ten years or more, as shown by age-standardised net survival for patients diagnosed with Hodgkin lymphoma during 2010-2011 in England and Wales.[1] Out of 20 common cancers in England and Wales, ten-year survival for Hodgkin lymphoma ranks 4th highest overall. This relatively high survival is mainly a result of improvements in treatment over time, including advances in radiotherapy technology and more effective combinations of anti-cancer drugs.[2]

Hodgkin Lymphoma (C81), Net Survival up to Ten Years after Diagnosis, Adults (Aged 15-99), England and Wales, 2010-2011

Survival for Hodgkin lymphoma is reported in Scotland and Northern Ireland,[3,4] though it is difficult to make survival comparisons between countries due to different methodologies and criteria for including patients in analyses.

References

  1. Data were provided by London School of Hygiene and Tropical Medicine on request, 2014.
  2. Flowers CR, Armitage JO. A Decade of Progress in Lymphoma: Advances and Continuing Challenges Clin Lymphoma Myeloma. Leuk 2010;10(6):414-23.
  3. ISD Scotland. Trends in Cancer Survival 1983-2007.
  4. Northern Ireland Cancer Registry. Incidence & Survival 1993-2012.

About this data

Data is for: England and Wales, 2010-2011, ICD-10 C81

Last reviewed:

Five-year survival for Hodgkin lymphoma is highest in the youngest men and women and decreases with increasing age. Five-year net survival in men ranges from 95% in 15-39 year-olds to 23% in 80-99 year-olds for patients diagnosed with Hodgkin lymphoma in England during 2009-2013.[1] In women, five-year survival ranges from 94% to 33% in the same age groups.

Hodgkin Lymphoma (C81), Five-Year Net Survival by Age, England, 2009-2013

Last reviewed:

As with most cancers, survival for Hodgkin lymphoma is improving. Some of the increase is likely to be attributable to changes in the diagnosis, classification and registration of Hodgkin lymphoma, so interpretation of these trends should be undertaken with caution.

One-year age-standardised Open a glossary item net survival for Hodgkin lymphoma in men has increased from 74% during 1971-1972 to 91% during 2010-2011 in England and Wales – an absolute survival difference Open a glossary item of 17 percentage points.[1] In women, one-year survival has increased from 77% to 92% over the same time period (a difference of 15 percentage points).

Hodgkin Lymphoma (C81), Age-Standardised One-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011

Five- and ten-year survival has increased by an even greater amount than one-year survival since the early 1970s. Five-year age-standardised net survival for Hodgkin lymphoma in men has increased from 54% during 1971-1972 to a predicted survival of 84% during 2010-2011 in England and Wales – an absolute survival difference of 30 percentage points.[1] In women, five-year survival has increased from 59% to 86% over the same time period (a difference of 27 percentage points).

Hodgkin Lymphoma (C81), Age-Standardised Five-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011

Five-year survival for 2010-2011 is predicted using an excess hazard statistical model

Ten-year age-standardised net survival for Hodgkin lymphoma in men has increased from 45% during 1971-1972 to a predicted survival of 79% during 2010-2011 in England and Wales – an absolute survival difference of 34 percentage points.[1] In women, ten-year survival has increased from 51% to 83% over the same time period (a difference of 32 percentage points). Overall, 8 in 10 people diagnosed with Hodgkin lymphoma today are predicted to survive their disease for at least ten years.

Hodgkin Lymphoma (C81), Age-Standardised Ten-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011

Ten-year survival for 2005-2006 and 2010-2011 is predicted using an excess hazard statistical model

References

  1. Data were provided by London School of Hygiene and Tropical Medicine on request, 2014.

About this data

Data is for: England and Wales, 1971-2011, ICD-10 C81

Last reviewed:

Five-year relative survival for Hodgkin lymphoma in men in England (78%) is similar to the average for Europe (80%). Wales (76%), Scotland (80%) and Northern Ireland (84%) are also similar to the European average.[1] Across the European countries for which data is available, five-year relative survival in men ranges from 57% (Bulgaria) to 85% (Norway).[1

Five-year relative survival for Hodgkin lymphoma in women in England (80%) is below the average for Europe (82%). Wales (78%) and Scotland (82%) are similar to the European average.[1] No five-year survival data is available for Northern Ireland. Across the European countries for which data is available, five-year relative survival in women ranges from 65% (Bulgaria) to 89% (Slovenia).[1

Hodgkin lymphoma (C81), Age-Standardised Five-Year Relative Survival, Adults (Aged 15+), European Countries, 2000-2007

Data consists of both observed and predicted 5-year relative survival. Where sufficient follow-up was not available for recently diagnosed patients the period approach was used to predict 5-year cohort survival.

Possible explanations for persistent international differences in survival include differences in cancer biology, use of diagnostic tests and screening, stage at diagnosis, access to high-quality care, and data collection practices.[1]

References

  1. De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 - a population-based study. Lancet Oncol 2014;15:23-34

About this data

Data is for: 29 European countries, patients diagnosed in 2000-2007 and followed up to 2008, Hodgkin lymphoma (International Classification of Diseases for Oncology [ICD-O-3] C81).

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.

Rate this page:

Currently rated: 3.4 out of 5 based on 13 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page